论文信息 - Reduction in platelet counts as a mechanistic biomarker and guide for adaptive dose-escalation in phase I studies of the Bcl-2 family inhibitor ABT-263 - 字舞流文

Reduction in platelet counts as a mechanistic biomarker and guide for adaptive dose-escalation in phase I studies of the Bcl-2 family inhibitor ABT-263

W. Wilson | C. Rudin | A. Roberts | O. O’Connor | L. Gandhi | H. Xiong | Y. Chiu | A. Krivoshik | D. Khaira | R. Greco